ChrysCap emerges as front runner to invest in Mumbai bulk-drugs maker

Premium
Credit: Pexels

Homegrown private equity firm ChrysCapital has emerged as the primary suitor to clinch an investment in a Mumbai-based drugmaker, two people familiar with the development told VCCircle. The PE firm will likely pick up a significant minority stake in bulk drug and formulations company BDR Pharmaceuticals Internationals Pvt. Ltd, one of ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.